• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharmaceuticals

Hikma Pharmaceuticals PLC

+ Add to Watchlist


59.8700 USD 1.8400 3.17%

As of 20:10:00 ET on 07/01/2014.

Snapshot for Hikma Pharmaceuticals PLC (HKMPY)

Open: 58.7800 Day's Range: 58.7800 - 59.8700 Volume: 240
Previous Close: 58.0300 52wk Range: 32.7500 - 59.8700 1-Yr Rtn: -

Stock Chart for HKMPY

No chart data available.
  • HKMPY:US 59.8700
  • 1D
  • 1M
  • 1Y
Interactive HKMPY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HKMPY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 23.8907
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 2.5060
Est. PEG Ratio 1.0919
Market Cap (M USD) 5,940.02
Shares Outstanding (M) 99.22
30 Day Average Volume 155
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.14%
Cash Dividend (USD) 0.3200
Dividend Ex-Date 04/23/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HKMPY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HKMPY

Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on developing, manufacturing, and marketing a range of both branded and non-branded generic and in-licensed pharmaceutical products. The Company's operations are conducted in the United States, the Middle East, and North Africa region, as well as Europe.

Mazen Samih Taleb DarwazahVice Chairman/CEO:MENASaid Sameeh Talib DarwazahChief Executive Officer
Michael Raya "Mike"President & CEO:USKhalid NabilsiChief Financial Officer
More Company Profile & Key Executives for HKMPY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil